Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection-Reference-Cited by-同舟云学术

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection

Published:2019-02-18 Issue:7 Volume:54 Page:641-649
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Suda Goki, ,Hasebe Chitomi,Abe Masami,Kurosaki Masayuki,Itakura Jun,Izumi Namiki,Uchida Yoshihito,Mochida Satoshi,Haga Hiroaki,Ueno Yoshiyuki,Abe Kazumichi,Takahashi Atsushi,Ohira Hiromasa,Tsukuda Yoko,Furuya Ken,Baba Masaru,Yamamoto Yoshiya,Kobayashi Tomoe,Inoue Jun,Terasita Katsumi,Ohara Masatsugu,Kawagishi Naoki,Izumi Takaaki,Nakai Masato,Sho Takuya,Natsuizaka Mitsuteru,Morikawa Kenichi,Ogawa Koji,Sakamoto Naoya

Funder

AMED

KAKEN

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-019-01556-y/fulltext.html

Reference41 articles.

1. Iwasa Y, Otsubo S, Sugi O, et al. Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan. Clin Exp Nephrol. 2008;12:53–7.

2. Bergman S, Accortt N, Turner A, et al. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis. 2005;45:684–9.

3. Fabrizi F, Plaisier E, Saadoun D, et al. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis. 2013;61:623–37.

4. Masakane I, Nakai S, Ogata S, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2013). Ther Apher Dial. 2015;19:540–74.

5. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int. 2008;73:S1–S99.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

2. Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response;JGH Open;2023-05-29

3. Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy;Therapeutic Apheresis and Dialysis;2023-05-22

4. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

5. Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C;Viruses;2023-01-07